HeXun Biosciences Co., Ltd.

TPEX:6986 Stock Report

Market Cap: NT$3.3b

HeXun Biosciences Balance Sheet Health

Financial Health criteria checks 6/6

HeXun Biosciences has a total shareholder equity of NT$550.6M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$613.0M and NT$62.3M respectively. HeXun Biosciences's EBIT is NT$116.3M making its interest coverage ratio -54.6. It has cash and short-term investments of NT$277.8M.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ratio-54.6x
CashNT$277.84m
EquityNT$550.63m
Total liabilitiesNT$62.35m
Total assetsNT$612.97m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 6986's short term assets (NT$391.5M) exceed its short term liabilities (NT$30.9M).

Long Term Liabilities: 6986's short term assets (NT$391.5M) exceed its long term liabilities (NT$31.5M).


Debt to Equity History and Analysis

Debt Level: 6986 is debt free.

Reducing Debt: 6986 had no debt 5 years ago.

Debt Coverage: 6986 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 6986 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies